Skip to main content
Log in

Aknetherapie in der Schwangerschaft

Acne therapy in pregnancy

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Eine Aknetherapie ist auch in der Schwangerschaft notwendig, um eine Verschlechterung, Narbenbildung, Superinfektion oder psychische Beeinträchtigung der Mutter zu verhindern. Sichere Produkte müssen ausgewählt werden. Tetrazykline, Doxyzyklin, Minozyklin oder Isotretinoin sind nicht einzusetzen. Topisches Benzoylperoxid und topische Azelainsäure sind sichere Therapiemöglichkeiten. Eine systemische Therapie kann bei ausgeprägt schwerer Akne nach den Leitlinien auch in der Schwangerschaft mit Glukokortikoiden ab dem 2. Trimenon in Zusammenarbeit mit dem Gynäkologen und/oder mit Erythromycin (Letzteres nicht in der Stillzeit) durchgeführt werden. Zink kann, falls nötig, oral gegeben werden, jedoch nicht länger als 3 Monate. Ergänzende kosmetologische Maßnahmen sind das manuelle Ausreinigen, Peeling-Maßnahmen wie ein mechanisches Peeling oder ein chemisches Peeling mit Glykol- oder Fruchtsäuren. Dagegen sollten Salicylsäure-, Trichloressigsäure- oder Phenol-Peels in der Schwangerschaft nicht eingesetzt werden. Camouflage kann die psychische Belastung seitens der Haut deutlich reduzieren.

Abstract

Acne should be treated during pregnancy to prevent worsening, scarring, secondary infection or psychological impairment of the mother. Safe products must be chosen. Systemic tetracycline, doxycycline, minocycline or isotretinoin can not be used. Topical benzoyl peroxide or topical azelaic acid are safe therapeutic options. According to the guidelines, systemic corticosteroids or systemic erythromycin (the latter not in lactation) can be employed beginning in the second trimester for severe flares of acne and should be started in cooperation with the patient’s gynecologist. Oral zinc is another option, but not for longer than 3 months. Accessory cosmetic measures may be useful, including mechanical peeling or chemical peeling with glycolic or alpha-hydroxy-acids. In contrast, salicylic acid, trichloracetic acid or phenol peels should not be performed in pregnancy. Camouflage makeup can clearly lower the psychological stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Akhavan A, Bershad S (2004) Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 4:473–492

    Article  Google Scholar 

  2. American Academy of Pediatrics Committee on Drugs (1994) The transfer of drugs and other chemicals into human milk. Pediatrics 93:137–150

    Google Scholar 

  3. Autret E, Berjot M, Jonville-Berra AP et al (1997) Anophthalmia and agenesis of optic chiasm associated with adapalene gel in early pregnancy. Lancet 350:339

    Article  PubMed  CAS  Google Scholar 

  4. Barza M, Goldstein JA, Kane A et al (1982) Systemic absorption of clindamycin hydrochloride after topical application. J Am Acad Dermatol 7:208–214

    Article  PubMed  CAS  Google Scholar 

  5. Bayerl C, Degitz K, Meigel E, Kerscher M (2010) Adjuvant dermato-cosmetic acne therapy. JDDG 1:S89–S94

    Article  Google Scholar 

  6. Becker LE, Bergstresser PR, Whiting DA et al (1981) Topical clindamycin therapy for acne vulgaris: a cooperative clinical study. Arch Dermatol 117:482–485

    Article  PubMed  CAS  Google Scholar 

  7. Borglund E, Hagermark O, Nord CE (1984) Impact of topical cindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris. Scand J Infect Dis S43:76–81

    Google Scholar 

  8. Cooper WO, Griffin MR, Arbogast P et al (2002) Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 156:647–650

    PubMed  Google Scholar 

  9. Cosmetic Ingredient Review Panel (2003) Safety assessment of Salicylic acid, Butyloctyl Salicylate, Calcium Salicylate, C12–15 Alkyl Salicylate, Caproyl Salicylic Acid, Hexyldodcyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Athylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, and Tridecyl Salicylate. Int J Toxicol 22:1–108

    Google Scholar 

  10. Cunliffe WJ, Gollnick HPF, Orfanos CE (1993) Akne. Hippokrates, Stuttgart

  11. Dréno B, Blouin E (2008) Acne, pregnant women and zinc salts: a literature review. Ann Dermatol Venerol 135:27–33

    Article  Google Scholar 

  12. Duran B, Gursoy S, Cetin M et al (2004) The oral toxicity of resorcinol during pregnancy: a case report. J Toxicol Clin Toxicol 42:663–666

    Article  PubMed  CAS  Google Scholar 

  13. Fluhr JW, Gloor M, Merkel W et al (1998) Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Multicentre, ranmdomized, vehicle controlled, double-blind study on 91 acne patients with acne papulopustulosa (Plewig and Kligman’s grade II–III). Arzneimittelforschung 48:188–196

    PubMed  CAS  Google Scholar 

  14. Gallagher JC, Ismail MA, Aladjem S (1980) Reduced urinary levels with erythromycin therapy. Obstet Gynecol 56:318–382

    Google Scholar 

  15. Gollnick H (1993) Azelaic acid – pharmacology, toxicology and mechanism of action on keratinization in vitro and in vivo. J Dermatol Treat 4:S3–S7

    Article  Google Scholar 

  16. Gollnick H, Cunliffe W, Berson D et al (2003) Global alliance to improve outcomes in acne. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 49:S1–S37

    Article  PubMed  Google Scholar 

  17. Hale EK, Pomeranz MK (2002) Dermatologic agents during pregnancy and lactation: an update and clinical review. Int J Dermatol 41:197–203

    Article  PubMed  Google Scholar 

  18. Krautheim A, Gollnick H (2003) Transdermal penetration of topical drugs used in the treatment of acne. Clin Pharmacokinet 42:1287–304

    Article  PubMed  CAS  Google Scholar 

  19. Kretschmar R, Leuschner F (1975) Investigation on the toxicity of tretinoin administered systemically to animals. Acta Derm Venereol S74:25–28

    Google Scholar 

  20. Lammer EJ, Chen DT, Hoar RM et al (1985) Retinoid acid embryopathy. N Engl J Med 313:837–841

    Article  PubMed  CAS  Google Scholar 

  21. McCormack WM, George H, Donner A et al (1977) Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrobe Agents Chemother 12:630–635

    Article  CAS  Google Scholar 

  22. Milstone EB, McDonald AJ, Scholhamer CF Jr (1981) Pseudomembranous colitis after topical application of clindamycin. Arch Dermatol 117:154–155

    Article  PubMed  CAS  Google Scholar 

  23. Morsches B, Holzmann H (1982) Studies on the percutaneous absorption if benzoyl peroxide. Arzneimittel Forschung 32:298–300

    PubMed  CAS  Google Scholar 

  24. Nacht S, Young D, Beasley JN et al (1981) Benzoyl peroxide percutaneous penetration and metabolic disposition. J Am Acad Dermatol 4:31–37

    Article  PubMed  CAS  Google Scholar 

  25. Nast A, BayerlC, Borelli C et al (2010) S2k-guideline for therapy of acne. JDDG 8 S2:1–59

    Google Scholar 

  26. Nau H (1993) Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmakol 6:35–44

    Article  Google Scholar 

  27. Parry MF, Rha CK (1986) Pseudomembranous colitis caused by topical clindamycin phosphate. Arch Dermatol 122:583–584

    Article  PubMed  CAS  Google Scholar 

  28. Rothman KF, Pochi PE (1988) Use of oral and topical agents for acne in pregnancy. J Am Acad Dermatol 19:431–442

    Article  PubMed  CAS  Google Scholar 

  29. Sasseville D (1996) Dermatological therapy during pregnancy and lactation. In: Harahap, M, Wallach RC (Hrsg) Skin changes and disease in pregnancy. Marcel Dekker, New York, S 249–319

  30. (o A) (2011) Skin-lightening cosmetics: frequent, potentially severe adverse effects. Prescrire Int 20:209–213

    Google Scholar 

  31. Stéphan F, Revuz J (2004) Zinc salts in dermatology. Ann Dermatol Venerol 13:455–460

    Article  Google Scholar 

  32. Tauber U, Weiss C, Matthes H (1992) Percutaneous absorption of azelaic acid in humans. Exp Dermatol 1:176–179

    Article  PubMed  CAS  Google Scholar 

  33. Van Hoogdalem EJ (1998) Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol 11 S1:13–19

    Google Scholar 

  34. Weinstein AJ, Gibbs RE, Gallagher M (1976) Placental transfer of clindamycin and gentamicin in term pregnancy. Am J Obstet Gynecol 124:688–691

    PubMed  CAS  Google Scholar 

  35. Worret WI, Fluhr JW (2006) Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. JDDG 4:293–300

    Article  PubMed  Google Scholar 

  36. Zbinden G (1975) Aspects of teratology of vitamin A acid (beta-all-trans- retinoic acid). Acta Derm Venerol S74:36–40

    Google Scholar 

Download references

Interessenkonflikt

Die korrespondierende Autorin weist auf folgende Beziehungen hin: Unterstützung zu Symposien, Vorträgen und Aufwandsentschädigungen für Studien und Advisory-Board-Tätigkeiten von Firmen, die Aknepräparate, Peelingsubstanzen und Camouflage-Produkte herstellen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Bayerl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayerl, C. Aknetherapie in der Schwangerschaft. Hautarzt 64, 269–273 (2013). https://doi.org/10.1007/s00105-012-2456-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-012-2456-2

Schlüsselworter

Keywords

Navigation